Research location
Moline
Illinois, United States
Advertisement
Research activity in Moline
Illinois, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 123 trials and 238 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Moline
123 linked trials · page 2 of 3A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-InhibitorNCT01283971 · 2011-05-01 · 1 site observation
TERMINATED
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerNCT01251861 · 2011-03-17 · 1 site observation
COMPLETED
Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056NCT01296711 · 2011-03-07 · 1 site observation
TERMINATED
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 4 site observations
ACTIVE_NOT_RECRUITING
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT00828009 · 2011-01-17 · 1 site observation
COMPLETED
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) TherapyNCT01242488 · 2010-11-01 · 1 site observation
COMPLETED
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerNCT01101438 · 2010-08-13 · 1 site observation
COMPLETED
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast CancerNCT01091454 · 2010-06-01 · 2 site observations
COMPLETED
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerNCT01041781 · 2010-02-01 · 4 site observations
TERMINATED
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung CancerNCT00976677 · 2010-01-01 · 6 site observations
TERMINATED
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisNCT01008423 · 2009-11-20 · 1 site observation
COMPLETED
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisNCT01007435 · 2009-10-31 · 1 site observation
COMPLETED
Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen TherapyNCT00956813 · 2009-10-01 · 2 site observations
COMPLETED
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeNCT00968708 · 2009-09-01 · 1 site observation
COMPLETED
Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerNCT00986674 · 2009-09-01 · 6 site observations
COMPLETED
An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyNCT00973479 · 2009-09-01 · 1 site observation
COMPLETED
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive StageNCT00887159 · 2009-07-16 · 6 site observations
COMPLETED
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerNCT00946712 · 2009-07-15 · 4 site observations
TERMINATED
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerNCT00878709 · 2009-07-09 · 1 site observation
COMPLETED
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)NCT00891020 · 2009-05-01 · 1 site observation
COMPLETED
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementNCT00869206 · 2009-03-01 · 2 site observations
COMPLETED
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast CancerNCT00820872 · 2009-02-01 · 2 site observations
COMPLETED
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyNCT00769379 · 2008-12-10 · 4 site observations
COMPLETED
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesNCT00874211 · 2008-12-01 · 2 site observations
COMPLETED
Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerNCT00776100 · 2008-10-01 · 2 site observations
TERMINATED
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerNCT00601900 · 2008-09-24 · 6 site observations
COMPLETED
RESTART C0168Z05 Rheumatoid Arthritis StudyNCT00714493 · 2008-07-01 · 1 site observation
COMPLETED
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination ChemotherapyNCT00693992 · 2008-06-15 · 4 site observations
COMPLETED
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and EtoposideNCT00632853 · 2008-03-01 · 4 site observations
COMPLETED
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerNCT00567580 · 2008-02-01 · 1 site observation
UNKNOWN
Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week DosingNCT00647270 · 2007-12-01 · 1 site observation
COMPLETED
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerNCT00433511 · 2007-11-02 · 6 site observations
ACTIVE_NOT_RECRUITING
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEUNCT00520975 · 2007-11-01 · 5 site observations
TERMINATED
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerNCT00516698 · 2007-09-01 · 2 site observations
COMPLETED
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00454194 · 2007-09-01 · 2 site observations
COMPLETED
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerNCT00423917 · 2007-08-01 · 2 site observations
COMPLETED
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in SituNCT00438659 · 2007-08-01 · 2 site observations
COMPLETED
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryNCT00324805 · 2007-07-19 · 7 site observations
COMPLETED
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00326599 · 2007-06-01 · 2 site observations
COMPLETED
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)NCT00476996 · 2007-05-15 · 1 site observation
TERMINATED
Maraviroc in Rheumatoid ArthritisNCT00427934 · 2007-02-01 · 1 site observation
TERMINATED
A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)NCT00443443 · 2007-01-01 · 1 site observation
COMPLETED
Pilocarpine in Treating Vaginal Dryness in Patients With Breast CancerNCT00343382 · 2006-12-01 · 2 site observations
COMPLETED
Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyNCT00337077 · 2006-11-01 · 5 site observations
COMPLETED
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast CancerNCT00666731 · 2006-10-12 · 1 site observation
COMPLETED
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerNCT00382070 · 2006-08-01 · 2 site observations
UNKNOWN
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node DissectionNCT00376597 · 2006-06-01 · 2 site observations
COMPLETED
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other CancerNCT00296036 · 2006-06-01 · 2 site observations
COMPLETED
A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid ArthritisNCT00424294 · 2006-06-01 · 1 site observation
TERMINATED
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07 · 6 site observations
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.